Home › Neuroendocrine Tumors › Michigan
Neuroendocrine Tumors clinical trials in Michigan
8 studies for Neuroendocrine Tumors are looking for participants at sites in Michigan.
Cities in Michigan
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- University of Michigan Hospitals, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06805825Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Henry Ford Cancer- Detroit, Detroit
- The Cancer and Hematology Centers, Grand Rapids
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06943755Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Barbara Ann Karmanos Cancer Institute, Detroit
- BAMF Health, Grand Rapids
- Michigan Health Professionals, Troy
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated Oct 13, 2026 · NCT05636618Project: Every Child for Younger Patients With Cancer
- C S Mott Children's Hospital, Ann Arbor
- Bronson Battle Creek, Battle Creek
- Children's Hospital of Michigan, Detroit
- and 14 more
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
- University of Michigan Comprehensive Cancer Center, Ann Arbor
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07132645A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- START Midwest, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT06943521SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Ann Arbor
- Massive Bio SYNERGY-AI site, Lansing
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
- Karmanos Cancer Institute, Detroit
Recruiting
Ages 18 and older · All sexes · Updated Aug 26, 2025 · NCT06908629From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.